» Articles » PMID: 34638564

Gut Microbiota and Dietary Factors As Modulators of the Mucus Layer in Inflammatory Bowel Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Oct 13
PMID 34638564
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal tract is optimized to efficiently absorb nutrients and provide a competent barrier against a variety of lumen environmental compounds. Different regulatory mechanisms jointly collaborate to maintain intestinal homeostasis, but alterations in these mechanisms lead to a dysfunctional gastrointestinal barrier and are associated to several inflammatory conditions usually found in chronic pathologies such as inflammatory bowel disease (IBD). The gastrointestinal mucus, mostly composed of mucin glycoproteins, covers the epithelium and plays an essential role in digestive and barrier functions. However, its regulation is very dynamic and is still poorly understood. This review presents some aspects concerning the role of mucus in gut health and its alterations in IBD. In addition, the impact of gut microbiota and dietary compounds as environmental factors modulating the mucus layer is addressed. To date, studies have evidenced the impact of the three-way interplay between the microbiome, diet and the mucus layer on the gut barrier, host immune system and IBD. This review emphasizes the need to address current limitations on this topic, especially regarding the design of robust human trials and highlights the potential interest of improving our understanding of the regulation of the intestinal mucus barrier in IBD.

Citing Articles

Understanding Predictors of Crohn's Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn's Disease.

Neustaeter A, Leibovitzh H, Turpin W, Croitoru K J Can Assoc Gastroenterol. 2025; 7(1):68-77.

PMID: 39834755 PMC: 10836969. DOI: 10.1093/jcag/gwad052.


Recognizing the biological barriers and pathophysiological characteristics of the gastrointestinal tract for the design and application of nanotherapeutics.

Li S, Wu T, Wu J, Chen W, Zhang D Drug Deliv. 2024; 31(1):2415580.

PMID: 39404464 PMC: 11485891. DOI: 10.1080/10717544.2024.2415580.


Studies on the Probiotic, Adhesion, and Induction Properties of Artisanal Lactic Acid Bacteria: to Customize a Gastrointestinal Niche to Trigger Anti-obesity Functions.

Kamber A, Bulut Albayrak C, Harsa H Probiotics Antimicrob Proteins. 2024; .

PMID: 39382740 DOI: 10.1007/s12602-024-10357-6.


Christensenella minuta protects and restores intestinal barrier in a colitis mouse model by regulating inflammation.

Kropp C, Tambosco K, Chadi S, Langella P, Claus S, Martin R NPJ Biofilms Microbiomes. 2024; 10(1):88.

PMID: 39294159 PMC: 11411060. DOI: 10.1038/s41522-024-00540-6.


Intestinal Fibrogenesis in Inflammatory Bowel Diseases: Exploring the Potential Role of Gut Microbiota Metabolites as Modulators.

Cicchinelli S, Gemma S, Pignataro G, Piccioni A, Ojetti V, Gasbarrini A Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675450 PMC: 11053610. DOI: 10.3390/ph17040490.


References
1.
Wawrzyniak P, Noureddine N, Wawrzyniak M, Lucchinetti E, Kramer S, Rogler G . Nutritional Lipids and Mucosal Inflammation. Mol Nutr Food Res. 2020; 65(5):e1901269. DOI: 10.1002/mnfr.201901269. View

2.
Sicard J, Le Bihan G, Vogeleer P, Jacques M, Harel J . Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front Cell Infect Microbiol. 2017; 7:387. PMC: 5591952. DOI: 10.3389/fcimb.2017.00387. View

3.
Martin R, Chamignon C, Mhedbi-Hajri N, Chain F, Derrien M, Escribano-Vazquez U . The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response. Sci Rep. 2019; 9(1):5398. PMC: 6443702. DOI: 10.1038/s41598-019-41738-5. View

4.
Zhao F, Zhou G, Liu X, Song S, Xu X, Hooiveld G . Dietary Protein Sources Differentially Affect the Growth of Akkermansia muciniphila and Maintenance of the Gut Mucus Barrier in Mice. Mol Nutr Food Res. 2019; 63(23):e1900589. DOI: 10.1002/mnfr.201900589. View

5.
Digby-Bell J, Atreya R, Monteleone G, Powell N . Interrogating host immunity to predict treatment response in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2019; 17(1):9-20. DOI: 10.1038/s41575-019-0228-5. View